Cilostazol to prevent a second stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether the drug cilostazol can help prevent another stroke or mini-stroke (TIA) in people who have already had one. It compares adding cilostazol to the standard blood-thinning medicines you and your doctor would normally use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have had an ischemic stroke or a high-risk mini-stroke within the last 180 days.
- You have at least two of these risk factors: age 65 or older, high blood pressure, diabetes, a prior stroke, current smoker, peripheral artery disease, coronary artery disease, significant plaque in the aorta, or significant narrowing of a major brain artery.
- You must be on a standard anti-clotting medicine (aspirin, clopidogrel, or ticagrelor) as directed by your doctor.
- You do not have atrial fibrillation, a mechanical heart valve, or a ventricular assist device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This study tests whether a combination of two blood-thinning medications (clopidogrel and rivaroxaban) is better than standard treatment (aspirin alone or aspirin plus clopidogrel) for preventing another stroke in people who have a narrowed artery inside the brain. It aims to reduce the risk of future strokes while managing bleeding risks.
This study tests whether the drug cilostazol, when added to your usual aspirin or clopidogrel, can help prevent another stroke. It is being done in Africa and may be a good option if you've recently had a stroke or mini-stroke and want to lower your risk of another one.
This trial tests whether the drug cilostazol can help prevent another stroke and slow down damage to the brain's small blood vessels. It may be a good option if you have recently had a small-vessel stroke and have white matter changes on your MRI.
Hear when a new Stroke Recurrence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.